IP Library Assignment 057981/0156
Patent Assignment
Reel/Frame 057981/0156

Security Interest

Recorded: 2021-11-01 Pages: 8
Assignors
METAGENICS, INC.
Executed: 2021-11-01
METAPROTEOMICS, LLC
Executed: 2021-11-01
Assignee
FORTRESS CREDIT CORP., AS COLLATERAL AGENT
1345 AVENUE OF THE AMERICAS, 46TH FLOOR, NEW YORK, NEW YORK, 10105
Covered Properties (19)
Novel Anti-Inflammatory Cyclooxygenase Inhibitors
Patent: 8,158,160 →
Application: 10/008,778 →
Publication: US 2003/0091656
Curcuminoid Compositions Exhibiting Synergistic Inhibition of the Expression and/or Activity of Cyclooxygenase-2
Patent: 6,979,470 →
Application: 10/198,277 →
Publication: US 2003/0108628
Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2
Patent: 7,332,185 →
Application: 10/280,198 →
Publication: US 2003/0113393
Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2
Patent: 7,195,785 →
Application: 10/480,145 →
Publication: US 2005/0042317
Synergistic Anti-Inflammatory Pharmaceutical Compositions and Related Methods Using Curcuminoids or Methylxanthines
Patent: 8,092,846 →
Application: 10/590,424 →
Publication: US 2007/0185213
Compositions That Treat or Inhibit Pathological Conditions Associated with Inflammatory Response
Patent: 7,270,835 →
Application: 10/689,856 →
Publication: US 2004/0151792
Synergistic Anti-Inflammatory Pharmaceutical Compositions and Related Methods Using Curcuminoids or Methylxanthines
Patent: 7,914,831 →
Application: 10/789,817 →
Publication: US 2005/0191375
Curcuminoid Compositions Exhibiting Synergistic Inhibition of the Expression and/or Activity of Cyclooxygenase-2
Patent: 7,279,185 →
Application: 10/988,393 →
Publication: US 2005/0129791
Protein Kinase Modulation by Hops and Acacia Products
Patent: 8,263,139 →
Application: 11/501,393 →
Publication: US 2007/0042063
Anti-Inflammatory Botanical Products for the Treatment of Metabolic Syndrome and Diabetes
Patent: 8,206,753 →
Application: 11/635,305 →
Publication: US 2007/0281045
Methods and Compositions for Heavy Metal Detoxification
Patent: 8,241,674 →
Application: 12/030,335 →
Publication: US 2009/0155382
Methods and Compositions for Promoting Bone and Joint Health
Patent: 8,815,306 →
Application: 12/048,613 →
Publication: US 2008/0242690
Synergistic Anti-Inflammatory Pharmaceutical Compositions and Related Methods Using Curcuminoids or Methylxanthines
Patent: 8,193,201 →
Application: 13/073,388 →
Publication: US 2011/0172253
Methods and Compositions for Heavy Metal Detoxification
Patent: 8,475,850 →
Application: 13/352,831 →
Publication: US 2012/0189721
Novel Anti-Inflammatory Cyclooxygenase Inhibitors
Patent: 8,609,154 →
Application: 13/448,623 →
Publication: US 2012/0270951
Phytonutrient Compositions and Methods to Protect Against Radical Mediated Cellular and Dna Damage
Application: 13/715,794 →
Publication: US 2013/0156870
Novel Anti-Inflammatory Cyclooxygenase Inhibitors
Patent: 8,846,115 →
Application: 14/072,748 →
Publication: US 2014/0066520
Compositions and Methods for Managing Digestive Disorders and a Healthy Microbiome
Application: 15/651,108 →
Publication: US 2018/0015032
Composition of Curcumagalactomannoside and Hops Extract
Application: 16/536,449 →
Publication: US 2020/0046651
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 14, 2012
From: TRIPP, MATTHEW L.; KONDA, VEERA; HALL, AMY; DESAI, ANU
To: METAPROTEOMICS, LLC
Reel/Frame 027698/0470 →
Assignment of Assignor's Interest Mar 16, 2012
From: BABISH, JOHN G.; TRIPP, MATTHEW L.; BLAND, JEFFREY S.
To: METAPROTEOMICS, LLC
Reel/Frame 027878/0772 →
Assignment of Assignor's Interest Jul 16, 2014
From: HELLER, ANDREA LYRA; CARROLL, BRIAN; TRIPP, MATTHEW L.; BLAND, JEFFREY S.
To: METAPROTEOMICS, LLC
Reel/Frame 033322/0093 →
Assignment of Assignor's Interest Aug 13, 2014
From: LIPOPROTEIN TECHNOLOGIES, INC.
To: METAPROTEOMICS, INC.
Reel/Frame 033527/0935 →
Release of Security Interest Oct 25, 2021
From: BANK OF AMERICA, N.A.
To: META PROTEOMICS, LLC
Reel/Frame 057909/0199 →
Security Interest Nov 4, 2021
From: METAGENICS, INC.; METAPROTEOMICS, LLC
To: FORTRESS CREDIT CORP. (AS COLLATERAL AGENT)
Reel/Frame 058015/0602 →
Assignment of Assignor's Interest Feb 16, 2024
From: METAPROTEOMICS, LLC
To: METAGENICS LLC
Reel/Frame 066485/0677 →
Security Interest Dec 22, 2025
From: METAGENICS LLC
To: WHITEHORSE CAPITAL ORIGINATION, LLC, AS AGENT
Reel/Frame 073293/0381 →
Termination and Release of Patent Security Agreement - Reel/Frame 058015/0602 Dec 23, 2025
From: FORTRESS CREDIT CORP.
To: METAGENICS LLC (FKA METAGENICS, INC.); METAPROTEOMICS, LLC
Reel/Frame 074050/0670 →
Termination and Release of Patent Security Agreement - Reel/Frame 057981/0156 Dec 24, 2025
From: FORTRESS CREDIT CORP.
To: METAGENICS LLC (FKA METAGENICS, INC.); METAPROTEOMICS, LLC
Reel/Frame 074057/0392 →